Estrogen-regulated feedback loop limits the efficacy of estrogen receptor–targeted breast cancer therapy
Tengfei Xiao(Lanzhou University), Myles Brown(Harvard University), Chongzhi Zang(University of Virginia Cancer Center), Qiu Wu(Shanghai Pulmonary Hospital), Peng Jiang(King Center), Nanlin Li(Xi'an Medical University), X. Shirley Liu(Harbin Medical University), Rinath Jeselsohn(Dana-Farber Cancer Institute), Jonathan Rennhack(Michigan State University), Mitch Dowsett(Institute of Cancer Research), Ying Huang(Mianyang Third People's Hospital), David Chi(Harvard University), Eran R. Andrechek(Michigan State University), Xiaoqing Wang(Roche (China)), Wei Li(Penn State Milton S. Hershey Medical Center), Han Xu(The University of Texas MD Anderson Cancer Center), Qi Liao(Ningbo University), Joseph Geradts(East Carolina University), Jixin Yang(Harvard University), Simone Detre(Royal Bournemouth Hospital)
Cited by 79
Related Papers
Model-based Analysis of ChIP-Seq (MACS)
|Genome biology|2008|20k
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
|Genome biology|2016|2.8k